AI-Powered Healthcare Innovation
for Research, Prevention & Better OutcomesSHOLYTICS develops AI research platforms advancing healthcare through clinical decision support, early detection, drug shortage prediction, and precision medicine — improving outcomes for patients across America.
About SHOLYTICS
An AI research company built for healthcare's hardest problems
SHOLYTICS LLC was founded to close the gap between what AI can do and what American healthcare actually deploys. We build specialized research platforms — not general-purpose tools — each designed around a specific, measurable failure in the U.S. health system.
Our flagship product, MedAI Care, is an AI-driven clinical platform built for hospitals and healthcare providers. Our research divisions — CancerAI, DrugAI, AIDSAI, America Health Grid, and Precision Medicine — each address a distinct national healthcare challenge with dedicated AI infrastructure.
Why SHOLYTICS
Built for institutions that demand rigorous AI
Founded by AI engineers, data scientists, and healthcare analytics specialists
Registered LLC in the Commonwealth of Kentucky — active since August 2025
Building six specialized AI research platforms targeting distinct healthcare gaps
Aligned with NIH, FDA, and CMS frameworks from day one
Designed for hospitals, universities, government agencies, and research institutions
HIPAA-compliant infrastructure architecture across all platforms
Legal Status
File No. 1486154 · Commonwealth of Kentucky
Filed August 19, 2025 · Status: Active
MedAI Care
AI-driven personalized clinical intelligence
MedAI Care is SHOLYTICS's primary commercial platform — an adaptive AI system that transforms clinical data into personalized treatment plans and real-time decision support for healthcare providers. Built for hospitals, clinics, specialty centers, and telehealth networks of all sizes.
Ensemble ML Engine
Deep neural networks, random forests, and support vector machines trained on EHR data, medical imaging, genomics, and wearable device inputs — working in concert to detect patterns no single model finds alone.
Real-Time Clinical Dashboard
Dynamic dashboards give clinicians immediate visibility into patient health trends, risk scores, and treatment response — enabling faster intervention before conditions escalate.
NLP on Clinical Notes
Advanced NLP parses unstructured clinical notes, research publications, and patient feedback to continuously refine predictive models with up-to-date evidence.
Patient Population Segmentation
Clustering algorithms segment patients into risk cohorts based on health characteristics, enabling targeted care protocols and identification of best practices across similar cases.
HIPAA-Compliant Infrastructure
Built on AWS and Azure with end-to-end encryption, audit trails, and SOC 2 Type II practices. Patient data never moves without explicit consent and documented authorization.
EHR System Integration
Connects with Epic, Oracle Health, and major EHR platforms through HL7/FHIR standards. No rip-and-replace — MedAI Care works inside the systems clinicians already use.
Subscription-Based Access for Healthcare Providers
MedAI Care operates on a tiered subscription model for institutions of all sizes — from single clinics to large hospital networks. Clinical training programs and advanced analytics packages available as add-ons.
Research Divisions
Six AI platforms targeting six
measurable healthcare gaps.
Each division is built around a specific failure point in U.S. healthcare — one with clear data, a defined patient population, and a concrete AI intervention.
MedAI Care
Adaptive AI platform using ensemble machine learning trained on EHR data, medical imaging, genomics, and real-time wearable inputs. Personalized treatment plans delivered in real-time to clinicians.
Addresses one-size-fits-all treatment protocols that produce suboptimal outcomes for a significant portion of patients annually.
CancerAI
AI-assisted cancer detection through radiology imaging analysis and genomic risk stratification. Clinical trial matching engine connects patients to relevant studies faster than manual methods.
Over 600,000 Americans die from cancer annually. Earlier detection through AI-assisted imaging analysis is one of the most impactful interventions available.
DrugAI
Predicts national drug shortages 6–12 months before they occur using FDA shortage database signals, manufacturer production data, and hospital inventory patterns — integrating with FDA's CDER Direct NextGen Portal.
Drug shortages delay or deny treatment for millions of patients — often for the most critical medications including chemotherapy agents and anesthetics.
AIDSAI
Treatment adherence monitoring, drug resistance forecasting, and public health spread modeling. Supports proactive outreach in underserved communities that lack regular access to infectious disease specialists.
New HIV infections remain concentrated in communities with the least access to specialist care. AI-assisted adherence monitoring and risk stratification can change those odds.
America Health Grid
AI-assisted telehealth triage for rural Americans, VA hospital integration, national outbreak early warning, and chronic disease prediction for underserved populations across all 50 states.
Rural Americans have shorter average life expectancies than urban counterparts — a gap driven primarily by delayed diagnosis and limited specialist availability.
Precision Medicine
Whole-genome analysis combined with lifestyle data and medical history generates individualized treatment recommendations. Aligned with NIH All of Us Research Program and pharmacogenomics research.
The same drug at the same dose produces vastly different outcomes based on individual genetics. Precision medicine eliminates that uncertainty before prescribing.
Measured Impact
The numbers behind
the problem
Americans affected by addressable healthcare gaps annually
CMS Value-Based Care Alignment
SHOLYTICS platforms align with CMS Hospital Value-Based Purchasing (VBP), Hospital Readmissions Reduction (HRRP), and HAC Reduction programs — delivering quality metrics that support Medicare participation.
FDA Drug Shortage Integration
DrugAI integrates with FDA's CDER Direct NextGen Portal and public shortage database. Predictive models provide 6–12 month early warning to hospital procurement teams.
NIH & NCI Research Collaboration
Seeking active collaboration with NIH, NCI, and CDC to validate AI models against national health datasets and contribute to peer-reviewed clinical research.
HIPAA-Compliant Infrastructure
All platforms built on HIPAA-compliant cloud infrastructure with end-to-end encryption, access audit trails, and SOC 2 Type II security practices.
Healthcare AI in Practice
From research to real lives
Each platform targets a distinct clinical environment — from hospital floors to rural telehealth.
MedAI Care
Real-time clinical decision support
CancerAI
AI-assisted early detection
DrugAI
Supply chain intelligence
America Health Grid
Rural & veteran healthcare access
Precision Medicine
Genomic AI analysis
MedAI Care
Real-time clinical decision support
CancerAI
AI-assisted early detection
DrugAI
Supply chain intelligence
America Health Grid
Rural & veteran healthcare access
Precision Medicine
Genomic AI analysis
Our Mission
Every American deserves care as rigorous as the science behind it
The gap between what AI can do and what healthcare actually deploys is measurable — in delayed diagnoses, avoidable drug shortages, and preventable complications. SHOLYTICS exists to close that gap, one research platform at a time.
Platform Overview
Full division breakdown
Adaptive AI platform using ensemble machine learning trained on EHR data, medical imaging, genomics, and real-time wearable inputs. Personalized treatment plans delivered in real-time to clinicians.
→AI-assisted cancer detection through radiology imaging analysis and genomic risk stratification. Clinical trial matching engine connects patients to relevant studies faster than manual methods.
→Predicts national drug shortages 6–12 months before they occur using FDA shortage database signals, manufacturer production data, and hospital inventory patterns — integrating with FDA's CDER Direct NextGen Portal.
→Treatment adherence monitoring, drug resistance forecasting, and public health spread modeling. Supports proactive outreach in underserved communities that lack regular access to infectious disease specialists.
→AI-assisted telehealth triage for rural Americans, VA hospital integration, national outbreak early warning, and chronic disease prediction for underserved populations across all 50 states.
→Whole-genome analysis combined with lifestyle data and medical history generates individualized treatment recommendations. Aligned with NIH All of Us Research Program and pharmacogenomics research.
→Why SHOLYTICS
Built for institutions that demand rigor
Universities, hospitals, NIH, and FDA take credibility seriously. Here is what SHOLYTICS brings to every engagement.
Registered Kentucky LLC
File No. 1486154 · Commonwealth of Kentucky · Filed August 19, 2025 · Status: Active
Academic Research Background
Founded by researchers with backgrounds in AI, software engineering, data science, and healthcare analytics. APSU affiliation.
AI & Software Engineering Expertise
Team expertise spans ML pipeline architecture, HIPAA-compliant cloud infrastructure, EHR integration, and clinical data engineering.
Healthcare Analytics Focus
Deep domain knowledge in CMS value-based care programs, FDA drug shortage frameworks, NIH research grant structure, and clinical decision support.
Mission-Driven Organization
Built to serve the public interest — targeting healthcare gaps that disproportionately affect rural, veteran, and underserved communities across the United States.
Compliance-First Architecture
Every platform designed from day one with HIPAA compliance, SOC 2 Type II practices, FDA data integration standards, and CMS quality reporting requirements.
Entity
SHOLYTICS LLC
File Number
1486154
State
Commonwealth of Kentucky
Filed
August 19, 2025
Status
Active
Leadership
The founding team
Four co-founders based in Clarksville, TN. Registered in Lexington, KY. Building from day one with a research-first approach.
Legal Entity
SHOLYTICS LLC
File No. 1486154 · KY · Active
Adekunle Adefabi
Co-Founder & CEO
Provides strategic vision and organizational leadership. Leads SHOLYTICS' mission to build AI-powered healthcare research platforms at national scale.
Ibrahim Olushola
Co-Founder & Chief Data Scientist
Directs ML pipeline architecture across all six platforms. Leads the AI systems behind MedAI Care and CancerAI research infrastructure.
Jesutoba Lopez
Co-Founder & Head of Technology
Builds HIPAA-compliant cloud infrastructure for global AI deployment. Leads EHR integration architecture and systems reliability.
Olamide Olasupo
Co-Founder & CFO
Guides financial strategy and sustainability. Manages capital planning, grant applications, and investor relations for SHOLYTICS.
Target Ecosystem
Partners we're building toward
Actively preparing proposals for universities, hospitals, government agencies, and technology leaders. Collaboration inquiries welcome.
AI & Cloud
Microsoft
Google Cloud
Amazon AWS
NVIDIA
OpenAI
Healthcare Tech
Epic Systems
Oracle Health
Philips Healthcare
GE HealthCare
Pharmaceutical
Pfizer
Moderna
Merck
Johnson & Johnson
Gilead Sciences
Universities
Harvard Medical School
Stanford Medicine
Johns Hopkins
MIT
Vanderbilt
Government
NIH
NCI
CDC
FDA
CMS
University and government proposals sent to: partnerships@sholytics.org · research@sholytics.org · grants@sholytics.org
Get In Touch
Partner with SHOLYTICS
We welcome proposals from universities, hospitals, government agencies, and investors aligned with our mission to advance AI-driven healthcare research.
General
management@sholytics.orgPartnerships
partnerships@sholytics.orgResearch
research@sholytics.orgGrants
grants@sholytics.orgRegistered Office
271 W. Short St Ste 410
Lexington, KY 40507
SHOLYTICS LLC
File No. 1486154 · Commonwealth of Kentucky
Filed August 19, 2025 · Status: Active
Or email directly: management@sholytics.org